Literature DB >> 31167251

Enhanced Thrombolysis by Ultrasound-Assisted Catheter-Directed Thrombolysis and Microbubbles in an In Vitro Model of Iliofemoral Deep Vein Thrombosis.

Rolf P Engelberger1,2, Verena Schroeder3, Michael Nagler4, Raja Prince5, Daniel Périard1, Daniel Hayoz1, Nils Kucher6.   

Abstract

There is a need to improve the efficacy and safety of catheter-directed thrombolysis (CDT) for thrombo-occlusive diseases, and ultrasound-assisted CDT (USAT) is a promising approach. We tested if thrombolysis efficacy of USAT can be improved by adding gaseous microbubbles (MB). We developed an in vitro dynamic overflow model for iliofemoral deep vein thrombosis, and added MB to an USAT system with ultrasound energy and dose of tissue plasminogen activator according to clinical practice. A total of 64 clots (mean baseline weight of 8.23 ± 1.12 g, generated from citrated human whole blood from 7 healthy male volunteers) were randomly assigned to 1 of 4 study protocols of 30 minutes' duration: negative control, CDT, USAT, and USAT + MB.Thrombolysis efficacy was assessed by measuring the change in D-dimer levels in the overflow liquid and the percentage of clot weight reduction. Compared to negative control, change in D-dimer increased by 62% (p = 0.017), 128% (p = 0.002), and 177% (p < 0.001) in the CDT, USAT, and USAT + MB groups, respectively. D-dimer increase was greater in the USAT than in the CDT group (p = 0.014), and greater in the USAT + MB than in the USAT group (p = 0.033). Compared to negative control, percentage of clot weight reduction increased by 123% (p = 0.016), 154% (p = 0.002), and 233% (p < 0.001) in the CDT, USAT, and USAT + MB groups, respectively. Percentage of clot weight reduction was greatest in the USAT + MB group (p < 0.05 compared with all other groups). In conclusion, our in vitro study suggests that the thrombolytic efficacy of USAT in human whole blood clots can be improved by local administration of MB. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31167251     DOI: 10.1055/s-0039-1688973

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Examining the Influence of Low-Dose Tissue Plasminogen Activator on Microbubble-Mediated Forward-Viewing Intravascular Sonothrombolysis.

Authors:  Leela Goel; Huaiyu Wu; Howuk Kim; Bohua Zhang; Jinwook Kim; Paul A Dayton; Zhen Xu; Xiaoning Jiang
Journal:  Ultrasound Med Biol       Date:  2020-05-07       Impact factor: 2.998

2.  The plasma D-dimer trends and their value in acute lower limb ischemia patients treated by catheter directed thrombolysis.

Authors:  Xiaochun Liu; Hailiang Xie; Guofu Zheng; Yuanfei Liu
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

3.  Future perspectives in catheter-based treatment of pulmonary embolism.

Authors:  Andrew S P Sharp; Antonious Attallah
Journal:  Eur Heart J Suppl       Date:  2019-11-21       Impact factor: 1.803

4.  Nanodroplet-mediated catheter-directed sonothrombolysis of retracted blood clots.

Authors:  Leela Goel; Huaiyu Wu; Bohua Zhang; Jinwook Kim; Paul A Dayton; Zhen Xu; Xiaoning Jiang
Journal:  Microsyst Nanoeng       Date:  2021-01-06       Impact factor: 7.127

5.  Enhanced thrombolysis by endovascular low-frequency ultrasound with bifunctional microbubbles in venous thrombosis: in vitro and in vivo study.

Authors:  Zhaojian Wang; Yunfan Pan; Huaigu Huang; Yuan Zhang; Yan Li; Chenghong Zou; Guanghua Huang; Yuexin Chen; Yongjian Li; Jiang Li; Haosheng Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.